Home>Topics>Stocks>Pharmaceutical Product Development

Pharmaceutical Product Development PPDI

  1. All
  2. Commentary
  3. Headlines
    1. Diamond Hill Small-Mid Cap Fund Fourth Quarter Commentary

      Headlines

      Wed, 1 Feb 2012

      and development services provider Pharmaceutical Product Development , Inc. was taken private during the ..... During the quarter, our position in Pharmaceutical Product Development , Inc. was eliminated as two private

    2. Diamond Hill Long-Short Fund Fourth Quarter Commentary

      Headlines

      Wed, 1 Feb 2012

      saturation. Eliminated Positions We eliminated our long positions in Pharmaceutical Product Development , Inc. and KLA-Tencor Corp. Pharmaceutical Product Development was acquired by two private equity firms while KLA-Tencor was eliminated

    3. Diamond Hill Research Opportunities Fund Fourth Quarter Commentary

      Headlines

      Wed, 1 Feb 2012

      Advent Software, Inc. Eliminated Positions We eliminated our long positions in Assurant, Inc. , Pharmaceutical Product Development , Inc. , Bristol-Myers Squibb Co. , Wal-Mart Stores, Inc. , National Penn Bancshares, Inc

    4. LPC-PPD to launch $1.325 bln buyout loan to retail syndication

      Headlines

      Fri, 4 Nov 2011

      NEW YORK, Nov 4 (LPC) - Pharmaceutical Product Development (PPD) is launching on November 8 at 10 a.m. the retail syndication of its buyout loan, sources said.

    5. PPD to Become a Private Company; Deal Value Close to our Fair Value Estimate

      Commentary

      Mon, 3 Oct 2011

      Pharmaceutical Product Development PPDI announced today that it will be acquired by private equity groups The Carlyle Group and Hellman & Friedman for $3.9 billion

    6. PPD appoints new CEO

      Headlines

      Mon, 19 Sep 2011

      (Reuters) - Pharmaceutical Product Development Inc said it has appointed Raymond Hill as chief executive officer, effective September 16, four months after David Grange retired as CEO.

    7. PPD Names New CEO

      Commentary

      Mon, 19 Sep 2011

      Pharmaceutical Product Development PPDI announced that it had hired an outsider as its key leader. Raymond H. Hill joined PPD as chief executive officer and a member

    8. Earnings Expansion, Strong Bookings in PPD's Second Quarter Signal Return to Growth for CRO Industry

      Commentary

      Wed, 27 Jul 2011

      Pharmaceutical Product Development PPDI turned in solid second-quarter results that fell in line with our expectations. The firm's strong earnings and new bookings

    9. PPD's Shares Rise on Buyout Rumors

      Commentary

      Mon, 18 Jul 2011

      Pharmaceutical Product Development 's PPDI shares rose sharply Monday on reports that the firm was putting itself up for sale. The company has declined to provide much detail

    10. PPD Turns In Strong 1Q Revenue and Bookings, but Lab Weighs on Earnings

      Commentary

      Wed, 27 Apr 2011

      In its first-quarter results, Pharmaceutical Product Development PPDI reported strong top- and bottom-line growth on a year-over-year basis. While operating profits doubled from the same period

    « Prev12345Next »
    Content Partners